Maria Isaac

Precompetitive Data Sharing as a Catalyst to Address Unmet Needs in Parkinson’s Disease

Arthur W. Toga, Max A. Little, Margaret Sutherland, 2015, Journal of Parkinson's disease.

Qualification opinion of novel methodologies in the predementia stage of Alzheimer's disease: Cerebro-spinal-fluid related biomarkers for drugs affecting amyloid burden — Regulatory considerations by European Medicines Agency focusing in improving benefit/risk in regulatory trials

Luca Pani, Spiros Vamvakas, Eric Abadie, 2011, European Neuropsychopharmacology.

Clinical Outcome Assessments: Conceptual Foundation-Report of the ISPOR Clinical Outcomes Assessment - Emerging Good Practices for Outcomes Research Task Force.

Elizabeth Molsen, Patrick Marquis, Jeremy Hobart, 2015, Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research.

On the edge of new technologies (advanced therapies, nanomedicines).

Spiros Vamvakas, Ruben Pita, S. Vamvakas, 2011, Drug discovery today. Technologies.

Trajectory analyses in alcohol treatment research.

Lei Liu, John O'Quigley, Jinsong Chen, 2012, Alcoholism, clinical and experimental research.

New pathway for qualification of novel methodologies in the European medicines agency

Efthymios Manolis, Spiros Vamvakas, E. Manolis, 2011, Proteomics. Clinical applications.

Biomarkers for Alzheimer's disease therapeutic trials

Nick C. Fox, Michael Weiner, Giovanni B. Frisoni, 2011, Progress in Neurobiology.

Assessing cognition and function in Alzheimer's disease clinical trials: Do we have the right tools?

Richard J. Caselli, Peter J. Snyder, Michael Grundman, 2014, Alzheimer's & Dementia.

Coalition Against Major Diseases/European Medicines Agency biomarker qualification of hippocampal volume for enrichment of clinical trials in predementia stages of Alzheimer's disease

Martha Brumfield, Robin Wolz, Marina Boccardi, 2014, Alzheimer's & Dementia.